Professor of Medicine, Director of Hep research&Tx Hep Fellowship | Studying Cirrhotic Cardiomyopathy | @montefioreNYC & @mayoclinic alumnus. Tweets are my own.
Pleased to share our AGA Clinical Practice Update on #MetALD: 9 best practice advice statements on diagnosis, fibrosis assessment, and management. Addressing metabolic risk and alcohol use together is central to care. @AGA_CGH
https://t.co/aaoFLXTTOA
AASLD is launching its first “Liver Care for Frontline Clinicians” program this fall on November 7 in Denver, Colorado, and I'll be speaking! View the full program online now: https://t.co/3V4xPwgnHL
Fibroscan is basically a liver vital sign
but it is 'unstructured data' so it is harder to include in studies than, e.g. bilirubin or BMI
Problem? Solved! By @AshleySpannMD in this @HepCommJournal paper https://t.co/uVd1dPTi4d
🗣️Compelling results for management of 🍻AUD using everyone’s fav GLP-1RAs 🦎:
Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial - The Lancet https://t.co/kVSfG1DxlX
Landmark prospective study led by our team @MASLDResearch Suzanne Sharpton @LuisAntonioDiaz and a global collaborative team @DrHuangDQ@AASLDtweets@EASLnews
Alimentary Pharmacology & Therapeutics | Pharmacology Journal | Wiley Online Library https://t.co/ygEgF8SpRX
We’re pleased to spread the word about the #ILTSCongress2026 in Geneva, May 6-9.
Join the global #livertransplantation community for cutting-edge science, hands-on workshops, and multidisciplinary exchange. @_ILTS_
Learn more: https://t.co/PFgdfGDqA9
Congratulations to the YI award 🥇 winners at #Baveno8!! @BavenoCoop ; Very excited for our Anahita Rabiee, rising star, along with our PORTAL network team members to present the first of several data on the real-world outcomes for patients with portal hypertension in North America! Grateful for leadership - Atoosa Rabiee, Christina Lindenmeyer, @DougSimonetto@manhalizzy@YucaSpice@JuanAbraldes@ggarciatsao and so many more!! Success in collaboration! 😁 👊
📑 Electronic decision aids enhance management of primary care patients with steatotic liver disease‼️
➡️ Automated, FIB-4–based guidance
➡️ Guideline adherence ⬆️ from 30% to 46%
One click closer to improved #MASLD care❕
https://t.co/HZ8n7QoQfb
AASLD AST Practice Guideline on adult liver transplantation: Diagnosis and post-transplant management of non-graft-related complications
https://t.co/xpONnZINPI
First #TLM2025 in the books!
Honored to receive the 2025 Early Career Investigator Award in Clinical/Translational Science & the opportunity to share our work on The Utility of Coronary CT Angiography vs. Dobutamine Stress in Predicting Obstructive CAD in LT eval @AASLDtweets
📢 The wait is over — regular abstracts are NOW LIVE! View the science and breakthrough research being presented at #TLM25@AASLDtweets. Start planning your schedule today. 🔗https://t.co/pOXEz51RiB
Thanks @VUMChealth@VUMCDiscoveries for highlighting our multidisciplinary study! We are thrilled for this milestone in the quest to explore #CirrhoticCardiomyopathy, its natural course and mechanisms over the next 5 years. Excited to work with my amazing collaborators #DeepakGupta @LisaVWMD https://t.co/ZZWhE610VK